A pharmacotherapy review of the novel, oral antithrombotics

Kara J. Walters, Anna Meador, John A. Galdo, Katharine N. Ciarrocca

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Coagulation disorders account for a high incidence of death in the U.S. due to stroke, myocardial infarction, and venous thromboembolism. In the past few years, numerous agents have been brought to market for the treatment of thromboembolism or prevention of thromboembolism. Similar to warfarin, these agents can cause bleeding disorders, which may exacerbate dental care treatment plans. This literature review examines the newer agents for the treatment of thromboembolism disorders, common side effects and drug interactions, the specific medical conditions each agent treats, and the dental perspective on how to medically management patients prescribed these medications.

Original languageEnglish (US)
Pages (from-to)62-70
Number of pages9
JournalSpecial Care in Dentistry
Volume37
Issue number2
DOIs
StatePublished - Mar 1 2017

Fingerprint

Thromboembolism
Drug Therapy
Dental Insurance
Venous Thromboembolism
Warfarin
Drug-Related Side Effects and Adverse Reactions
Drug Interactions
Tooth
Therapeutics
Stroke
Myocardial Infarction
Hemorrhage
Incidence

Keywords

  • anticoagulation
  • medical management
  • pharmacy
  • surgery

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Walters, K. J., Meador, A., Galdo, J. A., & Ciarrocca, K. N. (2017). A pharmacotherapy review of the novel, oral antithrombotics. Special Care in Dentistry, 37(2), 62-70. https://doi.org/10.1111/scd.12207

A pharmacotherapy review of the novel, oral antithrombotics. / Walters, Kara J.; Meador, Anna; Galdo, John A.; Ciarrocca, Katharine N.

In: Special Care in Dentistry, Vol. 37, No. 2, 01.03.2017, p. 62-70.

Research output: Contribution to journalArticle

Walters, KJ, Meador, A, Galdo, JA & Ciarrocca, KN 2017, 'A pharmacotherapy review of the novel, oral antithrombotics', Special Care in Dentistry, vol. 37, no. 2, pp. 62-70. https://doi.org/10.1111/scd.12207
Walters, Kara J. ; Meador, Anna ; Galdo, John A. ; Ciarrocca, Katharine N. / A pharmacotherapy review of the novel, oral antithrombotics. In: Special Care in Dentistry. 2017 ; Vol. 37, No. 2. pp. 62-70.
@article{0f1647ea4957489eae56246d1dc48814,
title = "A pharmacotherapy review of the novel, oral antithrombotics",
abstract = "Coagulation disorders account for a high incidence of death in the U.S. due to stroke, myocardial infarction, and venous thromboembolism. In the past few years, numerous agents have been brought to market for the treatment of thromboembolism or prevention of thromboembolism. Similar to warfarin, these agents can cause bleeding disorders, which may exacerbate dental care treatment plans. This literature review examines the newer agents for the treatment of thromboembolism disorders, common side effects and drug interactions, the specific medical conditions each agent treats, and the dental perspective on how to medically management patients prescribed these medications.",
keywords = "anticoagulation, medical management, pharmacy, surgery",
author = "Walters, {Kara J.} and Anna Meador and Galdo, {John A.} and Ciarrocca, {Katharine N.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1111/scd.12207",
language = "English (US)",
volume = "37",
pages = "62--70",
journal = "Special Care in Dentistry",
issn = "0275-1879",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - A pharmacotherapy review of the novel, oral antithrombotics

AU - Walters, Kara J.

AU - Meador, Anna

AU - Galdo, John A.

AU - Ciarrocca, Katharine N.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Coagulation disorders account for a high incidence of death in the U.S. due to stroke, myocardial infarction, and venous thromboembolism. In the past few years, numerous agents have been brought to market for the treatment of thromboembolism or prevention of thromboembolism. Similar to warfarin, these agents can cause bleeding disorders, which may exacerbate dental care treatment plans. This literature review examines the newer agents for the treatment of thromboembolism disorders, common side effects and drug interactions, the specific medical conditions each agent treats, and the dental perspective on how to medically management patients prescribed these medications.

AB - Coagulation disorders account for a high incidence of death in the U.S. due to stroke, myocardial infarction, and venous thromboembolism. In the past few years, numerous agents have been brought to market for the treatment of thromboembolism or prevention of thromboembolism. Similar to warfarin, these agents can cause bleeding disorders, which may exacerbate dental care treatment plans. This literature review examines the newer agents for the treatment of thromboembolism disorders, common side effects and drug interactions, the specific medical conditions each agent treats, and the dental perspective on how to medically management patients prescribed these medications.

KW - anticoagulation

KW - medical management

KW - pharmacy

KW - surgery

UR - http://www.scopus.com/inward/record.url?scp=85014506969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014506969&partnerID=8YFLogxK

U2 - 10.1111/scd.12207

DO - 10.1111/scd.12207

M3 - Article

VL - 37

SP - 62

EP - 70

JO - Special Care in Dentistry

JF - Special Care in Dentistry

SN - 0275-1879

IS - 2

ER -